Pancreatic ductal adenocarcinoma is an aggressive disease with an extremely low survival rate. This is due to the (i) poor prognosis and (ii) high resistance of the disease to current treatment options. The latter is partly due to the very complex and dense tissue/tumour microenvironment of pancreatic cancer, which contributes to the disease's progression and the inhibition of apoptotic pathways. Over the last years, advances in tissue engineering and the development of three-dimensional (3D) culture systems have shed more light into cancer research by enabling a more realistic recapitulation of the niches and structure of the tumour microenvironment. Herein, for the first time, 3D porous polyurethane scaffolds were fabricated and coated wi...
Cancer tissue engineering is an emerging multidisciplinary field aimed at growing cancerous cells on...
Cancer tissue engineering is an emerging multidisciplinary field aimed at growing cancerous cells on...
Pancreatic ductal adenocarcinoma (PDAC) is a disease notorious for poor therapeutic response and low...
Pancreatic ductal adenocarcinoma is an aggressive disease with an extremely low survival rate. This ...
Pancreatic ductal adenocarcinoma is an aggressive disease with an extremely low survival rate. This ...
Pancreatic ductal adenocarcinoma is an aggressive disease with an extremely low survival rate. This ...
Pancreatic ductal adenocarcinoma is an aggressive disease with an extremely low survival rate. This ...
Pancreatic cancer is the fourth leading cause of all cancer-related deaths in the United States, fif...
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly disease. This has...
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly disease. This has...
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly disease. This has...
Pancreatic ductal adenocarcinoma (PDAC) represents 85-90% of all pancreatic cancers and is the 11th ...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer that is a leading cause of can...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer that is a leading cause of can...
The cellular microenvironment is a network of structural and functional components that provide mech...
Cancer tissue engineering is an emerging multidisciplinary field aimed at growing cancerous cells on...
Cancer tissue engineering is an emerging multidisciplinary field aimed at growing cancerous cells on...
Pancreatic ductal adenocarcinoma (PDAC) is a disease notorious for poor therapeutic response and low...
Pancreatic ductal adenocarcinoma is an aggressive disease with an extremely low survival rate. This ...
Pancreatic ductal adenocarcinoma is an aggressive disease with an extremely low survival rate. This ...
Pancreatic ductal adenocarcinoma is an aggressive disease with an extremely low survival rate. This ...
Pancreatic ductal adenocarcinoma is an aggressive disease with an extremely low survival rate. This ...
Pancreatic cancer is the fourth leading cause of all cancer-related deaths in the United States, fif...
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly disease. This has...
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly disease. This has...
With a very low survival rate, pancreatic ductal adenocarcinoma (PDAC) is a deadly disease. This has...
Pancreatic ductal adenocarcinoma (PDAC) represents 85-90% of all pancreatic cancers and is the 11th ...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer that is a leading cause of can...
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer that is a leading cause of can...
The cellular microenvironment is a network of structural and functional components that provide mech...
Cancer tissue engineering is an emerging multidisciplinary field aimed at growing cancerous cells on...
Cancer tissue engineering is an emerging multidisciplinary field aimed at growing cancerous cells on...
Pancreatic ductal adenocarcinoma (PDAC) is a disease notorious for poor therapeutic response and low...